Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol, Bisoprolol, and Pyridostigmine in POTS
NCT02171988Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2014
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bisoprolol and pyridostigmine in postural orthostatic tachycardia syndrome (POTS) (4 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change of the subjective symptom survey result at 3 months. Started Mar 2014; status: completed.
02
Drugs
bisoprololpyridostigmine
03
Conditions
postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on NCT02171988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171988.